Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

News

Sygnature is proud of its many achievements, research collaborations and awards and delighted to publish these achievements wherever possible. Below you can read and hear about exciting new developments within the organization.

Filter by:

Drug Discovery News

Sygnature Discovery announces multi-target drug discovery deal with Sitryx Therapeutics

READ ARTICLE

News

Dr. Scott Pollack – IDO Inhibitors and their Pharmacological Effects

READ ARTICLE

News

Dr. Scott Pollack – Intracellular Enzyme Inhibitors in Small Drug Discovery

READ ARTICLE

News

Dr. Scott Pollack – Ensuring Strong Hit-to-Lead Discovery Projects in the Future

READ ARTICLE

DMPK Drug Discovery News

Sygnature Discovery announces ambitious expansion plans with addition of Alderley Park facility

READ ARTICLE

News

Sygnature Discovery proves commitment to cyber security

READ ARTICLE

News

Sygnature Discovery appoints Dr Andy Black as Non-executive Chairman

READ ARTICLE

News

Sygnature Discovery raises over £2,700 for Parkinson’s UK

READ ARTICLE

News

Strategic Vision with the Appointment of Andy Lindstrom as Director of Marketing

READ ARTICLE

News

Sygnature Discovery focuses on US expansion with the appointment of Dr Bill Marathias

READ ARTICLE

Blog DMPK Therapeutic Areas

Understanding and predicting brain penetration for CNS-targeted drugs

READ ARTICLE

News

British Toxicology Society Annual Meeting (Newcastle, 16-18 of April)

READ ARTICLE
MORE...

Upcoming Events

View All
30-01 Apr-May 2019

BioTrinity 2019

London, UK

VISIT WEBSITE
25-27 Mar 2019

BIO-Europe Spring 2019

Vienna, Austria

VISIT WEBSITE
24-26 Mar 2019

Fragments 2019: 6th…

Cambridge, UK

VISIT WEBSITE